Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Raymond James Financial, Inc. Common Stock (NY: RJF )

159.84 -0.55 (-0.34%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Raymond James Financial, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'
Raymond James Financial, Inc. (NYSE: RJF) is now valued more highly than JPMorgan Chase & Co. (NYSE: JPM), according to Jim Cramer. 
Via Benzinga
Evaluating Raymond James Finl: Insights From 8 Financial Analysts
Via Benzinga
Raymond James Financial Inc. (NYSE: RJF) Highlighted for Surprising Price Action
Via Investor Brand Network
Raymond James Financial Names Paul Shoukry President and CEO Successor, Announces Additional Key Leadership Changes
From Raymond James Financial
Via GlobeNewswire
Peering Into Raymond James Finl's Recent Short Interest
Via Benzinga
Expert Ratings For Raymond James Finl
Via Benzinga
Raymond James Finl: Q1 Earnings Insights
Via Benzinga
Preview: Raymond James Finl's Earnings
Via Benzinga
Reflections From The Middle Seat: An Allocators Journey To Private Capital Advisory
I left a limited partner seat in April 2022 to join the Private Capital Advisory team at Raymond James and have received many questions weekly since from both LPs and General Partners. 
Via Talk Markets
Best Stocks To Watch This Week - Sunday, March 17
In this video, I review the week's trading and discuss which stocks would be the best to keep an eye on as we move into the new week of trading. 
Via Talk Markets
Raymond James Maintains Outperform Rating for Host Hotels & Resorts: Here's What You Need To Know
Via Benzinga
Raymond James Financial Declares Quarterly Dividends on Common and Preferred Stock
From Raymond James Financial
Via GlobeNewswire
Bears covered shorts on this ETF, 3 stocks to pop on the shift
Bears have ditched their short positions on this ETF, admitting that they too see a bull case for the economy, and these are the stocks to get paid first 
Via MarketBeat
Topics Bonds ETFs Economy
Exposures Debt Markets Economy
Raymond James Is Souring on Carvana (CVNA) Stock
Raymond James issued a "sell" rating on Carvana. Here’s why betting against CVNA stock is a complicated proposition. 
Via InvestorPlace
Raymond James Maintains Strong Buy Rating for Patterson-UTI Energy: Here's What You Need To Know
Via Benzinga
Stock Market Boom: Top 3 Financial Stocks to Ride the Rally
The bull market will cause much more wealth to enter stocks, Here are three of the top names poised to benefit from a financial stocks boom. 
Via InvestorPlace
This Analyst Downgrades Tractor Supply Despite EPS Beat, Cites Short-Term Hurdles
Raymond James analyst Bobby Griffin downgrades Tractor Supply to Outperform, citing near-term earnings challenges post Q4 results. Despite a slight miss in sales and a beat in adjusted EPS, the analyst... 
Via Benzinga
Why Snowflake Stock Is Trading At New 52-Week High
Raymond James noted current public cloud trends as positive and specifically highlighted Amazon.com's fourth-quarter AWS revenue growth re-acceleration as favorable to Snowflake as its Cloud Data... 
Via Benzinga
Fastly, General Mills And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by more than 300 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Raymond James Maintains Strong Buy Rating for Marathon Petroleum: Here's What You Need To Know
Via Benzinga
Yes, Colgate-Palmolive can clean its way to a fresh all-time high
Colgate-Palmolive is in an upswing driven by analysts' sentiment and results; it may experience a price-multiple expansion and hit new highs this year 
Via MarketBeat
Colgate's Bright Smile: Analyst Envisions Upswing In 2024 Guidance With Ample Growth Opportunities
Raymond James analyst upgrades Colgate-Palmolive to Outperform and announces $91 price target. Strong Q4 earnings and 2024 outlook cited. 
Via Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Raymond James Finl: Here's What You Need To Know
Via Benzinga
Abbott Laboratories on track for new highs in 2024
Abbott Laboratories is a solid dividend play whose underlying business is returning to growth after years of COVID-19 impact. 
Via MarketBeat
Exposures COVID-19
Raymond James Financial Reports Fiscal First Quarter of 2024 Results
From Raymond James Financial
Via GlobeNewswire
Raymond James Maintains Outperform Rating for Golub Capital BDC: Here's What You Need To Know
Via Benzinga
Raymond James Maintains Outperform Rating for OceanFirst Financial: Here's What You Need To Know
Via Benzinga
Nvidia Poised for Continued Dominance in AI Infrastructure, Analysts Forecast Robust Growth
Raymond James reiterates Nvidia as a Strong Buy, raising the target from $600 to $700, backed by its dominance in Gen AI infrastructure. With new GPU launches and expansion in restricted markets,... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings Scheduled For January 24, 2024
Companies Reporting Before The Bell • Freeport-McMoRan (NYSE:FCX) is estimated to report quarterly earnings at $0.22 per share on revenue of $5.86 billion. 
Via Benzinga
Why AMD Stock Hit A New All-Time High This Week
Advanced Micro Devices shares are trading higher by 2.2% during Friday's session. Raymond James maintained a Strong Buy and raised its price target from $140 to $190. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.